摘要 |
<p>The subject invention pertains to novel compositions and methods for the treatment of tumors and angiogenic diseases. Specifically, these novel compositions and methods comprise combination therapies where FR4, or biologically-active mutants or fragments of PF4, are combined with various angiostatic, antitumor, or immunomodulatory compounds to provide enhanced levels of therapy.</p> |